Abstract:Objective:To observe the intervention of Zhilong Huoxue Tongyu capsale on aspirin resistance and its mechanism MethodS:60 patients with aspirin resistance were randomly divided into increasing aspirin dosage group,given Aspirin 300 mg/d;and Zhilong Huoxue Tongyu capsule group,given Zhilong Huoxue Tongyu capsule 1.6g,tid.After 4 consecutive weeks;PAG,TXB2,6-K-PGF1αand drug safety were observed and compared. Results:The effective rate in treatment group was significantly higher;AA and ADP induced platelet aggregation rate and its decreased value were significantly lower than that of the control group.After treatment TXB2 increased significantly in both groups(P<0.01).6-K-PGF1αin Zhilong Huoxue Tongyu capsule group was higher than increaseing group in aspirin dosage(P<0.05);after treatment,it was significantly lower in increasing aspirin dosage group(P<0.01.) After treatment,the amount of TXB2/6-K-PGF1αwas lower in both groups(P<0.01,0.05), The incidence of adverse drug reactions was significantly lower in treatment group than in control group.Conclusion: Zhilong Huoxue Tongyu capsule intreating aspirin resistance has better efficacy and safety,which may relate to the decrase of TXB2,increase of 6-K-PGF1α,and the decrease of TXB2/6-K-PGF1αthus effectively improving the AR.